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Abstract
Background: There is currently no mechanism in place outside of government to provide rapid syntheses of the
best available research evidence about problems, options and/or implementation considerations related to a
specific health system challenge that Canadian health system decision-makers need to address in a timely manner.
A ‘rapid-response’ program could address this gap by providing access to optimally packaged, relevant and high-quality
research evidence over short periods of time (i.e. days or weeks).
Methods: We prepared an issue brief that describes the best available research evidence related to the problem, three
broad features of a program that addresses the problem and implementation considerations. We identified
systematic reviews by searching for organization-targeted implementation strategies in Health Systems Evidence
(www.healthsystemsevidence.org) and drew on an existing analytical framework for how knowledge-brokering
organizations can organize themselves to operationalize the program features. The issue brief was then used to
inform a half-day stakeholder dialogue about whether and how to develop a rapid-response program for health
system decision-makers in Canada. We thematically synthesized the deliberations.
Results: We found very few relevant systematic reviews but used frameworks and examples from existing programs to
1) outline key considerations for organizing a rapid-response program,, 2) determine what can be done in timelines
ranging from 3 to 10 and 30 business days, and 3) define success and measure it. The 11 dialogue participants from
across Canada largely agreed with the content presented in the brief, but noted two key challenges to consider:
securing stable, long-term funding and finding a way to effectively and equitably manage the expected demand.
Recommendations and suggestions for next steps from dialogue participants included taking an ‘organic’ approach to
developing a pan-Canadian network and including jurisdictional scans as a type of product to deliver through
the program (rather than only syntheses of research evidence).
Conclusions: Dialogue participants clearly signalled that there is an appetite for a rapid-response program for
health system decision-makers in Canada. To ‘organically’ build such a program, we are currently engaging in
efforts to build partnerships and secure funding to support the creation of a pan-Canadian network for conducting
rapid syntheses for health system decision-makers in Canada.
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Background
A gap exists in efforts to support the use of research evi-
dence between ‘self-serve’ approaches (e.g. ‘one-stop
shops’ for research evidence such as Health Systems
Evidence - www.healthsystemsevidence.org) and ‘full-
serve’ approaches (e.g. convening stakeholder dialogues
with health system leaders who are informed by an evi-
dence brief that synthesizes the best available research
evidence). A ‘rapid-response’ program could fill this gap
in situations where health system decision-makers need
support with accessing and synthesizing optimally pack-
aged, relevant and high-quality research evidence over days
or weeks (i.e. when the timeline is too short to prepare a
full evidence brief and convene a stakeholder dialogue).
When looking for support to find and synthesize re-
search evidence in a timely manner, decision-makers
may turn to internal research-support services (many of
which use less systematic and transparent processes than
are typically used by formally designated programs) or
to researchers with whom they have an established rela-
tionship. Alternatively, they may turn to one of very few
formalized rapid-response programs in Canada, if their
question is about drugs and other health technologies
[1], if they are in Quebec and have a question about
drugs and other health technologies or about health and
social programs and services [2], if they are in Ontario
and pose a question related to HIV programs and ser-
vices [3] or if they are a manager or stakeholder working
within the Champlain Local Health Integration Network
[4,5]. However, there is currently no mechanism in place
outside of government to provide rapid syntheses of the
best available research evidence about problems, options
and/or implementation considerations related to a spe-
cific health system challenge (as opposed to a challenge
with a program, service or drug).
Depending on the timelines provided, products pro-
vided through a rapid-response program might include a
listing of relevant research evidence (if the timeline is
very short), a brief synthesis of the results (if the timeline
permits) or a more detailed summary (if given a longer
period of time). Some rapid-response programs also sup-
plement these products by conducting briefings with
decision-makers based on the research evidence identi-
fied [6]. One added benefit of providing rapid-response
programs is that decision-makers who have previously
used such services and found them to be valuable may
be more inclined to think about finding and using re-
search evidence in the future, and/or highlight the value
of doing so to their peers. Another added benefit is that
the products of a rapid-response program (which we will
call ‘rapid syntheses’) can be made available in a reposi-
tory for others to access (as effort to facilitate ‘user pull’
for research evidence) or be actively disseminated to pol-
icymakers in other settings (as a ‘push’ mechanism) who
may (or eventually will) be grappling with the same or
similar issues.
We see rapid syntheses as being distinct from a rapid
systematic review (and other variants such as rapid real-
ist review) in several ways. First, those requesting a rapid
synthesis typically set the timeline within which it needs
to be prepared (typically no more than a few weeks). In
contrast, a rapid review is typically a comprehensive sys-
tematic review conducted in a condensed timeline (e.g.
6 months), rather than a more standard timeline like 1
or 2 years. Second, the nature of the questions addressed
can take many forms, and relate to a problem, options
or implementation considerations, as opposed to a rapid
review of the effects of a single option. Lastly, rapid syn-
theses typically include existing systematic reviews and
occasionally single studies, whereas rapid reviews focus
on single studies.
We recently created a rapid-response program at the
McMaster Health Forum that provides a summary (what
we call a ‘rapid synthesis’) of research evidence based on
a systematic search for information about problems, op-
tions and/or implementation considerations related to a
specific health system challenge [7]. At present, current
funding allows us to complete four requests (over a 3,
10 or 30 business day time frame) per year for Ontario-
based knowledge users (e.g. policymakers, managers of
healthcare institutions, community-based organizations)
who are involved in decision-making about health
systems. Given that this service would likely benefit
knowledge users across the country, we convened a half-
day stakeholder dialogue in March 2014 focused on
whether and how to develop a rapid-response program
for health system decision-makers in Canada. As out-
lined in the discussion, based on feedback from dialogue
participants, requests can now be taken from knowledge
users outside of Ontario on a cost recovery basis and
additional funding is being sought to allow us to
complete a greater number of requests each year.
Methods
Convening stakeholder dialogues is one promising
approach to addressing health system issues (in this case,
how to best support timely access to the best available
research evidence about pressing health system issues).
Stakeholder dialogues are designed to support evidence-
informed decisions by pairing the best available research
evidence with a robust deliberative process that gives
stakeholders the opportunity to bring their tacit know-
ledge and their own views and experiences to bear on a
pressing health system problem, three options to address
it and implementation considerations [8]. Generally,
convening health system stakeholders (e.g. government
officials, professional and community leaders, patients/
citizens and groups representing them, and researchers)
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for deliberations has the overarching goal of supporting
participants to champion creative efforts to address a
pressing health system problem within their respective
constituencies [8]. Each dialogue is informed by an evi-
dence or issue brief that mobilizes the best available re-
search evidence about the problem, options and
implementation considerations. While using the same
approach as an evidence brief, issue briefs, such as the
one produced for this dialogue, draw on findings from a
previously conducted synthesis of the evidence or in the
absence of syntheses uses analytical frameworks to help
dialogue participants critically engage with the topic [8].
We describe below our methods for preparing the
issue brief and convening the dialogue. For those who
are interested in more detail, a separate paper outlines
the overall approach for developing evidence/issue briefs
and convening stakeholder dialogues [8].
Preparing the issue brief
We prepared the issue brief through four steps: 1) con-
vening a steering committee; 2) developing and refining
a terms of reference for an issue brief; 3) identifying,
selecting, appraising and extracting key findings from
the research evidence about the problem, program fea-
tures and implementation considerations; and 4) synthe-
sizing the findings in the form of an issue brief. Our
steering committee was comprised of representatives
from partner organizations and stakeholder groups and
provided guidance throughout the process as well as lit-
erature that would be relevant to preparing the brief.
The terms of reference for the issue brief provided a
preliminary outline to clarify the problem, framed three
options for addressing it (in this case, three broad fea-
tures of a program for addressing the problem given the
nature of the topic being addressed) and identified
implementation considerations. We developed and itera-
tively refined the terms of reference in collaboration
with our steering committee.
For the third stage, we identified relevant systematic
reviews related to the three program features (organizing
a rapid-response program, establishing what can be done
in what timelines and defining success and measuring it)
by searching Health Systems Evidence (www.healthsys-
temsevidence.org), which is a continuously updated
database, that contains (as of January 2015) 4,200
systematic reviews and more than 2,200 economic evalu-
ations of delivery, financial and governance arrange-
ments within health systems. For more information
about the sources searched to identify documents
included in Health Systems Evidence, see http://www.
healthsystemsevidence.org/why-use-it.aspx. The reviews
and economic evaluations were identified by searching
the category for organization-targeted implementation
strategies in Health Systems Evidence. The searches
were reviewed by one of us (MGW) with another (JNL)
checking reviews for which there was uncertainty about
their inclusion. For each systematic review, we extracted
the focus of the review, key findings, the last year the lit-
erature was searched, the methodological quality (based
on AMSTAR [9] ratings that are provided for all reviews
contained in Health Systems Evidence), the proportion
of included studies that were conducted in Canada and
the proportion of included studies focused explicitly on
supporting the use of research evidence. For any reviews
that had not been previously quality appraised using
AMSTAR, two reviewers (MGW and FPG) independ-
ently completed an assessment.
Given the nature of the topic, there are very few rele-
vant systematic reviews available, so we drew heavily on
an existing analytical framework for how knowledge-
brokering organizations can organize themselves [10].
We then used this framework to derive possible
organizational features of a rapid-response program for
health system decision-makers in Canada and to docu-
ment features of other rapid-response programs that are
focused on addressing questions related to health
systems (see the Results section for more about the
framework and our application of it). These other pro-
grams were identified through our own knowledge of
existing programs and by asking our steering committee
and key contacts about programs they were aware of.
We then conducted hand searches of each program web-
site to document organizational characteristics related to
the key domains of the analytical framework we noted
above (these broadly related to governance, management
and staffing, program resources and collaborations) as well
as key features of their methods and products.
Lastly, we drafted the brief by presenting the evidence
we identified in concise and accessible language. The
final version of the briefs consisted of a one-page sum-
mary of key messages followed by a more detailed
description of 1) the problem, 2) three broad features of
a program that could address the problem and 3) pos-
sible barriers to implementation of the options at the
levels of individuals, providers, organizations and sys-
tems. The brief was then merit reviewed by a small
number of policymakers, stakeholders and researchers to
ensure its system relevance and scientific rigour.
Convening the stakeholder dialogue
We worked collaboratively with the steering committee
to identify health system stakeholders (for this dialogue,
principally, government officials as well as some stake-
holders who are or have been involved in developing
and administering a rapid-response program). For each
dialogue we convene, we invite those who have the abil-
ity to 1) bring unique views and experiences to bear on
the challenge and learn from the research evidence and
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from others’ views and experiences and 2) champion
within their respective constituencies the actions that
will address the challenge creatively. Participants were
principally identified from suggestions provided by
members of the steering committee, which we supple-
mented by reviewing government directories and web-
sites of relevant organizations.
The dialogue was facilitated by one of us (JNL) and in-
cluded deliberations about the same topics addressed in
each of the three sections of the brief (problem, program
features and implementation considerations). These
were followed by a fourth deliberation about the next
steps that could be taken. Participants were sent the
brief 2 weeks before the dialogue and were requested to
read it before arriving. The goal was not to aim for con-
sensus per se, but rather provide a space where diver-
ging opinions could be shared and discussed and to
identify possible synergistic efforts among stakeholders.
In addition, the dialogue followed the Chatham House
Rule (i.e. ‘the information received during the meeting
can be used, but neither the identity nor the affiliation
of the speaker(s), nor that of any other participant,
may be revealed’) [11]. Lastly, each of us took notes dur-
ing the deliberations as we did not audio record the dia-
logue. We used these notes to draft a summary of the
dialogue by highlighting the key themes that emerged dur-
ing each deliberation, points of disagreement or general
consensus and the types of action that participants
thought could be taken following the dialogue. We ad-
hered to the Chatham House Rule by keeping the identity
of participants confidential in writing the summary.
Results
We present below a summary of the key findings from
the issue brief and the key themes of the deliberations.
For those who are interested in more information about
each, the issue brief [12] and dialogue summary [13] are
freely available on the McMaster Health Forum website
(www.mcmasterhealthforum.org).
Key findings from the issue brief
The problem
Despite a range of approaches that are available in
Canada to support health system decision-makers’ ef-
forts to find and use research evidence efficiently, signifi-
cant barriers and challenges exist. We identified the
following as key components of the problem:
 limited number of formalized supports in place to
provide decision-makers with rapid syntheses of the
best available research evidence about problems,
options and/or implementation considerations
related to health system challenges (i.e. providing
the right product at the right time);
 inconsistent interaction between researchers and
decision-makers to ensure that the priorities of
decision-makers are addressed (i.e. having the right
people developing products on the right issues); and
 uncertainty about what success looks like given the
long chain of potential causal relationships between
an intervention/program (e.g. a rapid-response
program) and relevant outcomes (e.g. whether
decision-makers’ needs are met and/or their use of
research evidence).
Three broad features of a program to address the problem
To promote discussion during the stakeholder dialogue
about the pros and cons of a potentially viable approach
to developing a rapid-response program for health sys-
tem decision-makers in Canada, we identified three
broad program features. The three program features
were developed and refined through consultation with
the steering committee and include activities related to
1) organizing a rapid-response program, 2) establishing
what can be done in what timelines and 3) defining suc-
cess and measuring it.
We did not identify any systematic reviews related to
organizing a program to support the use of research evi-
dence (program feature 1). What we do know is that it
is essential to match form to function when organizing
such a program [10]. To do so (and to foster delibera-
tions about doing so), we identified four organizational
features (governance, management and staffing,
resources and collaboration) from a recent policy sum-
mary designed to encourage debate and innovation
about the ways in which knowledge-brokering organiza-
tions organize themselves [10]. According to this policy
summary, knowledge brokering refers to the ‘use of
information-packaging mechanisms and/or interactive
knowledge-sharing mechanisms to bridge policy-makers’
and researchers’ contexts’, which encompasses many of
the proposed activities of the rapid-response program.
We outline these types of organizational features in
Table 1 along with possible approaches to operationaliz-
ing each of them.
The same policy summary also provides a set of nine
criteria for assessing organizational models for knowledge
brokering, which were derived from a multi-method study
consisting of a systematic review, scoping review of
knowledge-brokering mechanisms and models, website re-
view of existing knowledge-brokering organizations, sites
visits and case studies. The summary was designed for
those involved in establishing or leading organizations that
support the use of research evidence in developing health
policy [10]. The following nine criteria have been extracted
directly from Lavis et al. 2013 and ask whether a
knowledge-brokering organization [10]
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1. gives policymakers, stakeholders and researchers an
explicit role in its governance and ensures they
exercise their role with transparency and objectivity;
2. has and enforces rules that ensure independence in
how health system information is produced,
packaged and shared and that address conflicts of
interest;
3. grants the director the authority needed to ensure
the accountability of the entire organization to its
knowledge-brokering mandate;
Table 1 Summary of organizational features and possible approaches to operationalizing them (table from Wilson
et al. 2014) [12]
Organizational feature Possible approaches to operationalizing each feature Criteria meta
Governance (structure, scope and rules) ● Administer the rapid-response program through the McMaster Health Forum
under its existing governance structure that prioritizes strong links with and
involvement of policymakers and stakeholders in the programs it delivers
● 1, 7
● Operationalize this approach to governance by convening a rapid-response
program steering committee consisting of federal, provincial and territorial health
system decision-makers and stakeholders who can provide strategic guidance
about administering the program
● 1, 9
● Establish that the rapid-response program: ● 2
○ addresses topics requested by health system decision-makers (requests will
be submitted to the Forum through email and the questions will be refined by
the Forum in collaboration with the requestor where necessary);
○ ensures that the findings of the syntheses are based on the available
research evidence and not the personal views of those who requested or
developed it;
○ identifies whether any potential conflicts of interest exist in any product
produced through the rapid-response program; and
○ disseminates completed syntheses (e.g. through the existing Forum Update
newsletter and/or through a dedicated email list to the program partners) and
makes them available through a dedicated repository on the Forum’s website
(but without the requestor’s jurisdiction attached to the synthesis to provide
some level of anonymity)
Management and staffing ● Allocate authority to the organizational leadership of the Forum for ensuring
the accountability of the program in relation to its mandate
● 3
● Use effective project management processes to make the best use of available
resources and to sequence and prioritize tasks in a way that allows for all requests
to be completed within specified timelines
● 6
● Implement minimum training standards (e.g. completing an online training
course about finding and using research evidence) and provide ongoing mentorship
for staff contributing to the rapid-response program (this includes both those at the
Forum and from partner networks or organizations)
● 4
Program resources ● Seek external (but not user-pay) and long-term funding (e.g. from a Partnerships
for Health System Improvement grant from the Canadian Institutes of Health Research)
that will allow for both the delivery and ongoing evaluation of the program
● 5 (if
successful)
● Prioritize some requests over others in times when demand exceeds available
resources, which could be accomplished through one or more of the following
approaches:
● 6
○ completing requests from those who have not recently accessed the program;
○ requesting a resubmission at a later date for topics that are deemed less urgent
(either by the requestors themselves, by the steering committee or both); and/or
○ engaging the program steering committee to help decide which requests should
be prioritized (e.g. through a voting or ranking process over email)
Collaboration ● Engage trusted national, provincial and territorial partner networks or organizations
(where possible and necessary) to
● 8
○ identify whether a synthesis has already been completed on the topic (e.g. by
establishing a listserv that can be used to efficiently contact all partners when a request
is received) and
○ collaborate with the Forum to conduct syntheses (or build on existing products
identified) to ensure relevance to particular provincial and territorial contexts
aThe ordering of bullets in this column corresponds to the order in the adjacent column that lists possible approaches to operationalizing each feature.
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4. ensures an appropriate size, mix and capacity of staff
with knowledge-brokering responsibilities;
5. ensures an appropriate size of budget and an
appropriate mix of funding sources for knowledge-
brokering activities;
6. has an explicit approach to prioritizing knowledge-
brokering activities and accepting commissions or
requests from policymakers and stakeholders;
7. is located within another organization or network
that supports its knowledge-brokering activities;
8. collaborates with other knowledge-brokering
organizations in its knowledge-brokering activities; and
9. establishes functional linkages with policymaking
and stakeholder organizations.
In Table 1, we outline which of these criteria are met
by the possible approaches to operationalizing each pro-
gram feature.
We also documented features of several existing rapid-
response programs that target, at least in part, health
system decision-makers. We identified the programs in
collaboration with our steering committee as well as
from reviews of mechanisms designed to promote the
use of research evidence by policymakers [14,15] and
from our first-hand knowledge of existing programs. We
only included formally organized programs that are de-
signed to conduct rapid syntheses as their core task (as
opposed to support that may be offered informally
within government ministries or other organizations)
given that we were interested in how to formally
operationalize a rapid-response program. We docu-
mented the organizational features by reviewing their re-
spective websites, through our first-hand knowledge of
some of them, or based on input received from our pro-
ject steering committee. In the cases where we relied on
website review, informational gaps in our analysis may
exist. We provide a list of the programs and their
organization features in Additional file 1.
For program feature 2 (deciding what can be done in
what timelines), we identified three different timelines in
which a request can be made to the rapid-response pro-
gram (3, 10 or 30 business days), which we summarize
in Table 2. We identified several systematic reviews
evaluating interventions for supporting the use of re-
search evidence by policymakers, but each found insuffi-
cient evidence to draw conclusions about the
effectiveness of interventions [16-19]. While the evi-
dence is limited, one recent low-quality review found
evidence to suggest that tailored targeted messages com-
bined with access to registries of research evidence may
increase the use of research evidence in policymaking [17].
To supplement the limited synthesized research evidence,
we built on the profile of organizational characteristics of
rapid-response programs provided in Additional file 1 by
summarizing in Additional file 2 their target audience,
types of topics addressed and the products provided (and
the timelines in which they are produced).
For program feature 3 (defining success and measuring
it), we identified four short- and medium-term areas where
the success of a rapid-response program can be measured
using a brief survey administered following receipt of a
rapid synthesis and short interviews approximately
6 months later. The four areas of success include 1) pro-
gram organization (i.e. whether the program is organized
in a way that allows health system decision-makers to effi-
ciently make a request and receive a timely response), 2)
final product (e.g. was the synthesis presented in way that
was easy to understand?), 3) influence on behavioural
intention to use research evidence, and 4) whether and
how the synthesis was used. In Table 3, we outline each of
these potential areas of success and pair them with ap-
proaches to measuring whether we have been successful.
The only systematic reviews we identified for this pro-
gram feature related to the use of the theory of planned
behaviour. One older low-quality systematic review and an
older overview of systematic reviews from the psychology
field found that the theory explains approximately 39% of
the variance in intention and about 27% of the variance in
behaviour [20,21]. Linkages of a similar magnitude be-
tween intention and behaviour among healthcare profes-
sionals were found in another older but high-quality
systematic review [22], which lends support to it being
used in the study of health system decision-makers [23].
Implementation considerations
We identified several possible barriers to implementing
the program features, which we list in Table 4. In
addition, we identified possible windows of opportunity
for each program feature, which include
1. system leaders increasingly working collaboratively
to advance the timely translation of research
evidence to improve the financing, sustainability and
governance of the healthcare system (e.g. Evidence-
Informed Healthcare Renewal Roundtable) (program
feature 1);
2. the many lessons that have been learned from
existing rapid-response programs at the local,
national and international levels to decide what can
be done in what timeframes (program feature 2); and
3. approaches to evaluation used by other programs
that can be built upon to contribute to a broader
evidence base about whether and how rapid-response
programs work (program feature 3).
Summary of the dialogue
In addition to the facilitator (JNL) and two members of
the McMaster Health Forum team (MGW and FPG),
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Table 2 Summary of what can and cannot be done in what timelines (table from Wilson et al. 2014) [12]
Timeline What can be done What cannot be done
Three business days ● Identify systematic reviews and economic evaluations relevant
to health systems from key databases (e.g. Health Systems Evidence)
● Identify primary research studies (e.g.
published studies and unpublished
reports)
● Provide summary tables that outline ● Conduct quality appraisals for reviews
that are not available through Health
Systems Evidence○ key findings from relevant systematic reviews,
○ quality appraisals of systematic reviews (for reviews that are
available through Health Systems Evidence) and
● Prepare a detailed summary of key
findings
○ countries in which studies included in systematic reviews were
conducted (for reviews that are available in Health Systems Evidence)
● Engage experts to conduct a merit
review of the findings to ensure
scientific rigour and system relevance
● Conduct jurisdictional scans of what is
being done nationally and internationally
● Conduct a full systematic review
Ten business days ● Identify systematic reviews and economic evaluations relevant
to health systems from key databases (e.g. Health Systems Evidence)
● Identify grey literature (e.g.
unpublished reports) that is not
already contained in key databases
(e.g. Health Systems Evidence)
● Identify relevant primary research studies when limited evidence
is available from systematic reviews
● Prepare a detailed summary of key
findings
● Provide summary tables that outline ● Incorporate feedback from experts
engaged in the merit-review process
within the 10-day timeline (but a final
summary that incorporates reviewers’
feedback will be sent within another
five business days)
○ key findings from relevant systematic reviews,
○ quality appraisals of systematic reviews (for reviews that are
available through Health Systems Evidence) and
○ countries in which studies included in systematic reviews were
conducted (for reviews that are available in Health Systems Evidence)
● Prepare a brief summary of the key findings from systematic reviews
(and primary research studies where relevant)
● Conduct jurisdictional scans of what is
being done nationally and internationally
● Engage experts to conduct a merit review of the brief summary to
ensure scientific rigour and system relevance (a draft summary will be
submitted to the requester before merit reviewer feedback is received
and then a final summary that incorporates reviewers’ feedback will
be submitted within another five business days)
● Conduct a full systematic review
30 business days ● Identify systematic reviews and economic evaluations relevant
to health systems from key databases (e.g. Health Systems Evidence)
● Conduct a full systematic review
● Identify relevant primary research studies when limited evidence is
available from systematic reviews
● Conduct jurisdictional scans of what is being done nationally and
internationally through targeted searches of databases for published
literature, and websites of relevant jurisdictions and stakeholders for
grey literature that is not already contained in key databases (e.g.
Health Systems Evidence)
● Consult with experts with knowledge of the topic to identify
additional relevant research evidence (contingent on locating relevant experts)
● Provide summary tables that outline
○ key findings from relevant systematic reviews
○ quality appraisals of systematic reviews (for reviews that are
available through Health Systems Evidence) and
○ countries in which studies included in systematic reviews were
conducted (for reviews that are available in Health Systems Evidence)
● Prepare a detailed summary of the key findings from systematic
reviews (and primary research studies where relevant)
● Engage experts to conduct a merit review of the detailed summary
to ensure scientific rigour and system relevance and incorporate
reviewers’ feedback in the final report within the 30-business-day timeline
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Table 3 Summary of possible indicators of success and approaches to measuring success (table from Wilson et al.
2014) [12]
Where to measure success Possible approaches to measuring whether we have been successful
Program organization ● Brief survey asking the requestor to evaluate key features of the rapid-response
program (administered after receipt of rapid synthesis)
● Short qualitative interviews with requestors (conducted approximately 6 months
following receipt of rapid synthesis)
Final product (i.e. did the rapid synthesis meet the
requestor’s needs?)
● Brief survey asking the requestor to evaluate key features of the rapid synthesis
● Short qualitative interviews with requestors asking questions about what was most
and least helpful about the synthesis (6 months following receipt of rapid synthesis)
Influence on behavioural intention to find and use research
evidence
● Assessment of behavioural intention (and the attitudes, social norms and perceived
behavioural control that influence whether such intention translates into action) after
receiving the rapid synthesis and 6 months later (assessed in survey administered after
receipt of rapid synthesis and again during the short qualitative interviews 6 months later)
Whether and how the synthesis was used (i.e. did it
support evidence-informed decision-making?)
● Short qualitative interviews with requestors about how they used the rapid synthesis
(conducted 6 months following receipt of rapid synthesis)
Table 4 Potential barriers to implementing program features (table adapted from Wilson et al. 2014) [12]
Levels Potential barriers
Individual ● No barriers identified at the citizen or patient level for any of the program features
Service provider Program feature 1 - organizing a rapid-response program
● Existing providers of rapid-response programs may overlap to some extent with the scope of a new program focused on
producing rapid syntheses for health system decision-makers about problems, options and/or implementation considerations
related to a specific health system challenge
Program feature 2 - deciding what can be done in what timelines
● None identified
Program feature 3 - defining success and measuring it
● None identified
Organization Program feature 1 - organizing a rapid-response program
● Organizations may still lack the skills, structures, processes and a culture to promote and use research findings in
decision-making
Program feature 2 - deciding what can be done in what timelines
● None identified
Program feature 3 - defining success and measuring it
● None identified
System Program feature 1 - organizing a rapid-response program
● Decision-makers may be reluctant to rely on a rapid-response program established in another jurisdiction
● Decision-makers may be reluctant to make requests to an external rapid-response program for politically sensitive issues
or to publicly disclose that they made a request
● Decision-makers may face difficulties in developing a shared vision for a rapid-response program given their constraints
and competing priorities
Program feature 2 - deciding what can be done in what timelines
● Decision-makers may not be inclined to make requests to an external rapid-response program for very short timeframes
(e.g. 3 days) given that this may already be done internally on a routine basis
Program feature 3 - defining success and measuring it
● Decision-makers may be reluctant to fully disclose the impact of the rapid-response program, especially on politically
sensitive issues
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the dialogue brought together a diverse group of 11
stakeholders (nine policymakers/managers and two indi-
viduals from organizations that provide support to gov-
ernment decision-makers) from across Canada. Of these,
five joined the dialogue in-person and the remaining six
joined through video teleconference. The number of dia-
logue participants was purposefully lower than our typ-
ical range of 18 to 22 given our mix of in-person and
video participation, and the dialogue was purposefully
shorter than our usual full-day dialogue given our
smaller number of participants and the challenge of sus-
taining attention among video participants.
Dialogue participants generally agreed that health sys-
tem decision-makers faced the three general challenges
outlined earlier for finding and using research evidence.
During the deliberation about these challenges, partici-
pants emphasized five specific challenges. First, the diffi-
culty in accessing the best available research evidence in
a timely fashion was highlighted by many. It was specif-
ically noted that the definition of ‘timely’ often differs
significantly between researchers and decision-makers,
which poses challenges for accessing research evidence
through most researchers. Second, contextualizing the
research evidence was noted as being challenging but
critical for helping to identify what the research evidence
means for a particular jurisdiction at a given time. Third,
accessing expertise was raised as another challenge, par-
ticularly when there is only a limited body of research
evidence available from which to draw from. Fourth,
participants emphasized the lack of capacity to find and
use research evidence (particularly in smaller provinces
which may have few internal resources as compared to
larger provinces), both in terms of human resources and
organizational structures for ‘policy shops’ within minis-
tries of health. Lastly, ensuring the confidentiality of pol-
itically sensitive requests (e.g. those linked to
negotiations with professional organizations) was seen as
a challenge that would need to be addressed (particularly
if the products of a rapid-response program are rou-
tinely made publicly available).
Dialogue participants agreed with the core compo-
nents of the three program features and offered several
suggestions and/or challenges related to them. First,
while agreeing with many of the proposed organizational
features in program feature 1, most supported the sug-
gestion from one participant that the initial focus should
be on the ‘organic’ development of a pan-Canadian net-
work, with the McMaster Health Forum as a national
coordinating hub. With respect to what can be done in
what timelines (program feature 2), some questioned
whether the three-business-day product would be re-
quested often (given that many ministries of health
would do this type of work on their own), whether juris-
dictional scans about ‘who’s doing what’ could be offered
as a fourth type of product, the feasibility of consistently
preparing these products within the proposed timelines
and if the products can be translated to make them
available in both of the country’s official languages.
Lastly, participants noted challenges in the fourth area
of program feature 3 (measuring whether and how the
product was used). Specifically, several dialogue partici-
pants argued that it is difficult to assess the extent to
which a product informed or influenced a policy deci-
sion. In particular, participants emphasized that the
timeline for conducting the evaluation is unlikely to
align with the timelines for policy development and
decision-making processes (i.e. a decision, or the full se-
quence of decisions, is unlikely to be made soon after a
product is disseminated), thereby limiting the ability to
make definitive statements about whether and how a
product was used. In addition to the proposed measure-
ment approaches, participants suggested that the possi-
bility of capturing additional data from requestors
(before responding to the request) and from others who
could benefit from but did not make the request (e.g.
download statistics) would be worthwhile to explore.
The main challenges identified for moving forward
were securing stable, long-term funding and finding a
way to effectively and equitably manage the expected de-
mand. Dialogue participants indicated support for en-
gaging in a process to ‘organically’ build a pan-Canadian
network, which they saw as needing to support efforts to
1) develop a common vision for the network, 2) explore
how to link with organizations that could contribute to
establishing and maintaining the rapid-response net-
work, 3) map potential key individuals and organizations
that could be involved within their respective jurisdic-
tions that could contribute to the rapid-response net-
work and identify ways to bring them together, 4) find
‘kindred spirits’ in other provinces and territories (both
individuals and organizations) that could join a pan-
Canadian rapid-response network and 5) encourage
people to direct their health-system-related questions to
the newly established rapid-response network.
Discussion
Principal findings
We found very few systematic reviews related to the
three broad features (organizing a rapid-response pro-
gram, deciding what can be done in what timelines and
defining success and measuring it) of a rapid-response
program for health system decision-makers. However,
we used an existing analytical framework for how
knowledge-brokering organizations can organize them-
selves [10] to derive possible organizational features
(broadly related to governance, management and staff-
ing, program resources and collaborations). We also
documented features of other rapid-response programs
Wilson et al. Systematic Reviews  (2015) 4:25 Page 9 of 11
that are focused on addressing questions related to
health systems. In using the issue brief as a starting
point for a half-day stakeholder dialogue, the 11 partici-
pants from across Canada largely agreed with the con-
tent presented in the brief but noted two key challenges
to consider: securing stable, long-term funding and find-
ing a way to effectively and equitably manage expected
demand. In addition, the main recommendations and
suggestions for the next steps from dialogue participants
included 1) taking an ‘organic’ approach to developing a
pan-Canadian network (with the McMaster Health
Forum as the central hub), 2) including jurisdictional
scans as a type of product to deliver through the pro-
gram (rather than only syntheses of research evidence)
and 3) refining the evaluation approach to include add-
itional baseline information (e.g. their baseline intention
to use research evidence).
Strengths and limitations
The principal strength of our process is that we paired
an issue brief outlining research evidence, analytical
frameworks and characteristics of existing rapid-
response programs focused on health systems with a ro-
bust deliberative process that gave voice to the tacit
knowledge and real-world views and experiences of
those involved in and/or affected by the issue. The main
limitation is that we engaged a relatively smaller number
of dialogue participants (n = 11) than the 18 to 22 partic-
ipants that we have previously engaged in other stake-
holder dialogues and, hence, may have missed divergent
views held by some health system decision-makers
across the country.
Conclusions
Dialogue participants have clearly signalled that there is
an appetite for a rapid-response program for health sys-
tem decision-makers in Canada that addresses problems,
options and/or implementation considerations related to
a specific health system challenge. In light of the feed-
back about the need to ‘organically’ build such a pro-
gram, we are currently engaging in efforts to build
partnerships and secure funding to support the creation
of a pan-Canadian network for conducting rapid synthe-
ses for health system decision-makers in Canada. This
includes the key next steps noted in the summary of the
dialogue earlier, namely, developing a common vision
and exploring links with other organizations (including
funding organizations), networks and ‘kindred spirits’
that could join and contribute to sustaining a pan-
Canadian rapid-response network. We believe that
building such a network will make a significant contri-
bution to addressing a gap in knowledge translation
efforts for health system decision-makers in Canada.
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